FDA Inspection 1014205 — Gulf Coast Regional Blood Center at Westchase
The FDA completed an inspection of Gulf Coast Regional Blood Center at Westchase on February 7, 2017 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 7, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Houston, TX (United States)